Cite
Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.
MLA
Kim, Yeesuk, et al. “Comparative Safety and Effectiveness of Alendronate versus Raloxifene in Women with Osteoporosis.” Scientific Reports, vol. 10, no. 1, July 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41598-020-68037-8.
APA
Kim, Y., Tian, Y., Yang, J., Huser, V., Jin, P., Lambert, C. G., Park, H., You, S. C., Park, R. W., Rijnbeek, P. R., Van Zandt, M., Reich, C., Vashisht, R., Wu, Y., Duke, J., Hripcsak, G., Madigan, D., Shah, N. H., Ryan, P. B., & Schuemie, M. J. (2020). Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis. Scientific Reports, 10(1), 1–10. https://doi.org/10.1038/s41598-020-68037-8
Chicago
Kim, Yeesuk, Yuxi Tian, Jianxiao Yang, Vojtech Huser, Peng Jin, Christophe G. Lambert, Hojun Park, et al. 2020. “Comparative Safety and Effectiveness of Alendronate versus Raloxifene in Women with Osteoporosis.” Scientific Reports 10 (1): 1–10. doi:10.1038/s41598-020-68037-8.